The role of Akt and ERK in increased migration or invasion of neuroblastoma cells with high TRPM2 levels was examined following treatment with the Akt inhibitor afuresertib or the ERK inhibitor ravoxertinib. The gene discussed is MAPK1; the disease is neuroblastoma.